Medherant named as one of the 50 most innovative businesses in the Midlands
Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, is excited to announce it has been selected as one of the 50 m...
Medherant positions itself for the next stage of its development with the appointment of a new CEO
Coventry, UK, 25th June 2019 / Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as...
Medherant runner up in BVCA Management Team Awards
Medherant enjoyed a great evening at the Midlands BVCA Management Team Awards last night. The awards featured a number of leading businesses based in the Midlands and we were proud to be awarded runner up in the Venture-backed Management Team categor...
Mercia invests £2.0 million in transdermal drug delivery specialist, Medherant
Coventry, UK, 21st May 2019 / Medherant Limited (“Medherant”), the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million i...
Localised Pain Relief – Going straight to the source
Pain affects everyone at some time in their life, be it chronic arthritis or a one-off injury. Whilst the level of pain can vary hugely, even a small amount can significantly impact a person’s quality of life...
Medherant included in Silicone Republic Europe Start-up 100
Medherant has been included in the Silicone Republic Europe Start-up 100 for 2019 which looks at the companies to watch this year in e-commerce and fintech, deeptech, hardware and IoT, and medtech and life sciences. Despite Brexit uncertainty, the...
Medherant’s Year in Review – 2018
Last year was another busy year for Medherant with a significant milestone reached when we received positive results from the first clinical trials with our TEPI Patch® technology. We also received grant funding to develop plans for our own GMP...